Tri Ri Asset Management Corp Gilead Sciences, Inc. Transaction History
Tri Ri Asset Management Corp
- $136 Billion
- Q3 2024
A detailed history of Tri Ri Asset Management Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tri Ri Asset Management Corp holds 40,314 shares of GILD stock, worth $4.44 Million. This represents 2.33% of its overall portfolio holdings.
Number of Shares
40,314Holding current value
$4.44 Million% of portfolio
2.33%Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,289Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.9 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.55 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.01 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.9 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...